Spyre Therapeutics Ownership | Who Owns Spyre Therapeutics?
Spyre Therapeutics Ownership Summary
Spyre Therapeutics is owned by 102.13% institutional investors, 6.72% insiders. Fmr is the largest institutional shareholder, holding 14.93% of SYRE shares.
SYRE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Spyre Therapeutics | 102.13% | 6.72% | -8.85% |
| Sector | Healthcare Stocks | 42.51% | 10.81% | 46.68% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 9.06M | 14.93% | $151.85M |
| Fairmount funds management | 4.02M | 6.62% | $67.34M |
| Blackrock funding, inc. /de | 3.98M | 6.56% | $66.75M |
| Rtw investments, lp | 3.62M | 5.97% | $60.70M |
| Tang capital management | 3.20M | 5.27% | $53.63M |
| Vanguard group | 3.05M | 5.03% | $51.13M |
| Vr adviser | 2.69M | 4.42% | $45.01M |
| Braidwell lp | 2.58M | 4.25% | $43.21M |
| Capital investors | 2.39M | 3.94% | $40.10M |
| Driehaus capital management | 2.06M | 3.39% | $34.53M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Fairmount funds management | 4.02M | 6.06% | $67.34M |
| Vr adviser | 2.69M | 2.53% | $45.01M |
| Affinity asset advisors | 1.42M | 2.07% | $23.79M |
| Tang capital management | 3.20M | 2.06% | $53.63M |
| Commodore capital lp | 1.99M | 1.63% | $33.32M |
| Braidwell lp | 2.58M | 1.28% | $43.21M |
| B group | 100.00K | 1.23% | $1.68M |
| Boxer capital | 696.48K | 1.01% | $20.48M |
| Tcg crossover management | 1.10M | 0.91% | $18.45M |
| Highvista strategies | 215.75K | 0.89% | $3.62M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | 1.10M | 0.91% | 1.10M |
| Affinity asset advisors | 1.42M | 2.07% | 812.62K |
| Baker bros. advisors lp | 1.00M | 0.12% | 373.30K |
| Janus henderson group | 1.46M | 0.02% | 336.21K |
| Jpmorgan chase | 275.98K | 0.00% | 228.71K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Farallon capital management | - | - | -666.00K |
| Adage capital partners gp | - | - | -610.20K |
| Avoro capital advisors | - | - | -598.60K |
| Logos global management lp | - | - | -500.00K |
| First turn management | - | - | -464.44K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tcg crossover management | 1.10M | 0.91% | 1.10M | $18.45M |
| Parkman healthcare partners | 200.75K | 0.35% | 200.75K | $3.36M |
| Jane street group | 96.06K | 0.00% | 96.06K | $1.61B |
| Dimensional fund advisors lp | 84.22K | 0.00% | 84.22K | $1.41M |
| Schonfeld strategic advisors | 81.47K | 0.01% | 81.47K | $1.37M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Amundi | -5.00 |
| Pacific capital wealth advisors | -8.00 |
| Parallel advisors | -14.00 |
| True wealth design | -16.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 132 | 1.54% | 61,991,182 | -2.57% | 102 | 0.93% | 62 | -25.30% | 42 | 68.00% |
| Jun 30, 2025 | 129 | -1.53% | 63,612,503 | 9.51% | 104 | 37.19% | 81 | 10.96% | 26 | -23.53% |
| Mar 31, 2025 | 132 | 0.76% | 62,108,053 | 3.71% | 17 | 0.13% | 73 | -23.96% | 34 | 78.95% |
| Dec 31, 2024 | 120 | - | 50,788,525 | -1.15% | 99 | 0.78% | 86 | 19.44% | 18 | -25.00% |
| Sep 30, 2024 | 55 | -49.07% | 19,042,524 | -62.21% | 42 | 0.34% | 42 | -44.00% | 5 | -70.59% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 01, 2025 | Turtle Cameron | Chief Executive Officer | Sell | $119.47K |
| Dec 01, 2025 | Turtle Cameron | Chief Executive Officer | Sell | $315.89K |
| Nov 03, 2025 | Turtle Cameron | Chief Executive Officer | Sell | $651.23K |
| Nov 03, 2025 | Turtle Cameron | Chief Executive Officer | Sell | $398.55K |
| Sep 02, 2025 | Burrows Scott L | Chief Financial Officer | Sell | $299.64K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 1 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | 2 |
| 2024 Q3 | - | 1 |
SYRE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools